ID

DB00235|APRD00010||

名称

Milrinone

描述

A positive inotropic cardiotonic agent with vasodilator properties. It inhibits cAMP phosphodiesterase activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the ionotropic potency of amrinone.

cas号

78415-72-2

唯一标识码

JU9YAX04C7

状态

solid

组

approved,

指示

Indicated for the treatment of congestive heart failure.

药效学

Milrinone, a synthetic dimethylxanthine derivative structurally related to theophylline and caffeine, is used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.

作用机制

Milrinone inhibits erythrocyte phosphodiesterase, resulting in an increase in erythrocyte cAMP activity. Subsequently, the erythrocyte membrane becomes more resistant to deformity. Along with erythrocyte activity, Milrinone also decreases blood viscosity by reducing plasma fibrinogen concentrations and increasing fibrinolytic activity.

毒性

LD₅₀ = 0.3 mg/L in rats

代谢

There are five metabolites but the O-glucuronide represents the major pathway of biotransformation.

吸收

Milrinone is rapidly and almost completely absorbed after oral administration. Bioavailability is 92% (in healthy volunteers).

半衰期

2.3 hours

分类

description:This compound belongs to the class of organic compounds known as bipyridines and oligopyridines. These are organic compounds containing two pyridine rings linked to each other.
direct-parent:Bipyridines and oligopyridines
kingdom:Organic compounds
superclass:Organoheterocyclic compounds
class:Pyridines and derivatives
subclass:Bipyridines and oligopyridines
alternative-parent:3-pyridinecarbonitriles
alternative-parent:Azacyclic compounds
alternative-parent:Heteroaromatic compounds
alternative-parent:Hydrocarbon derivatives
alternative-parent:Hydroxypyridines
alternative-parent:Methylpyridines
alternative-parent:Nitriles
alternative-parent:Organooxygen compounds
alternative-parent:Organopnictogen compounds
substituent:3-pyridinecarbonitrile
substituent:Aromatic heteromonocyclic compound
substituent:Azacycle
substituent:Bipyridine
substituent:Carbonitrile
substituent:Heteroaromatic compound
substituent:Hydrocarbon derivative
substituent:Hydroxypyridine
substituent:Methylpyridine
substituent:Nitrile
substituent:Organic nitrogen compound
substituent:Organic oxygen compound
substituent:Organonitrogen compound
substituent:Organooxygen compound
substituent:Organopnictogen compound

消除途径

The primary route of excretion of milrinone in man is via the urine.

种类

Amines
D000588
Aminopyridines
D000631
Cardiac Stimulants Excl. Cardiac Glycosides

Cardiac Therapy

Cardiotonic Agents
D002316
Cardiovascular Agents
D002317
Compounds used in a research, industrial, or household setting
D020313
Drugs that are Mainly Renally Excreted

Enzyme Inhibitors
D004791
Hematologic Agents
D006401
Phosphodiesterase 3 Inhibitors
D058987
Phosphodiesterase 5 Inhibitors
D058986
Phosphodiesterase Inhibitors
D010726
Protective Agents
D020011
Pyridines
D011725
Vasodilating Agents
D014665

盐类

DBSALT000891Milrinone lactate9K8XR81MO8100286-97-3VWUPWEAFIOQCGF-UHFFFAOYSA-N301.302301.106255975

蛋白质结合

70 to 80%

清除

* 0.13 L/kg/hr [congestive heart failure patients, following IV injections of 12.5 mcg/kg to 125 mcg/kg] * 0.14 L/kg/hr [congestive heart failure patients, following infusions of 0.2 mcg/kg/min to 0.7 mcg/kg/min]

同义词

language:english; code:; name;1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile
language:spanish; code:inn; name;Milrinona
language:english/french; code:inn/usan; name;Milrinone
language:latin; code:inn; name;Milrinonum

国际品牌

CorotropCorotropeMilrila

配送量

* 0.38 liters/kg [intravenous injections of 12.5 mcg/kg to 125 mcg/kg to congestive heart failure patients] * 0.45 liters/kg [intravenous infusions of 0.20 mcg/kg/min to 0.70 mcg/kg/min to congestive heart failure patients]

产品

name:Apo-milrinone Injectable
labeller:Apotex Corporation
ndc-id:
ndc-product-code:
dpd-id:02249820
ema-product-code:
ema-ma-number:
started-marketing-on:2005-07-29
ended-marketing-on:2013-08-02
dosage-form:Solution
strength:
route:Intravenous
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Milrinone Injection
labeller:TEVA Canada Limited
ndc-id:
ndc-product-code:
dpd-id:02244811
ema-product-code:
ema-ma-number:
started-marketing-on:2003-05-25
ended-marketing-on:2015-07-22
dosage-form:Solution
strength:
route:Intravenous
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Milrinone Lactate
labeller:West Ward Pharmaceutical
ndc-id:
ndc-product-code:0641-6065
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-05-28
ended-marketing-on:
dosage-form:Injection
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA075530
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:West Ward Pharmaceutical
ndc-id:
ndc-product-code:0641-6067
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-05-28
ended-marketing-on:
dosage-form:Injection
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA075530
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Teva Parenteral Medicines, Inc.
ndc-id:
ndc-product-code:0703-8005
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-10-02
ended-marketing-on:2008-07-31
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA075852
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Teva Parenteral Medicines, Inc.
ndc-id:
ndc-product-code:0703-8006
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-10-02
ended-marketing-on:2008-06-30
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA075852
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Teva Parenteral Medicines, Inc.
ndc-id:
ndc-product-code:0703-8008
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2003-06-20
ended-marketing-on:2005-04-30
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA075852
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone lactate
labeller:Apotex Corporation
ndc-id:
ndc-product-code:60505-0718
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2004-09-21
ended-marketing-on:2010-07-01
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA076427
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone lactate
labeller:Apotex Corporation
ndc-id:
ndc-product-code:60505-0740
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2005-07-20
ended-marketing-on:2010-05-25
dosage-form:Injection
strength:20 mg/100mL
route:Intravenous
fda-application-number:ANDA077151
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Hospira Worldwide, Inc.
ndc-id:
ndc-product-code:61703-242
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-05-28
ended-marketing-on:2009-04-05
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA075830
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Hikma Farmaceutica
ndc-id:
ndc-product-code:62778-092
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-01-21
ended-marketing-on:2010-01-21
dosage-form:Injection, solution
strength:200 ug/1mL
route:Intravenous
fda-application-number:ANDA090038
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Hikma Farmaceutica
ndc-id:
ndc-product-code:62778-093
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-01-21
ended-marketing-on:2010-01-21
dosage-form:Injection, solution
strength:200 ug/1mL
route:Intravenous
fda-application-number:ANDA090038
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Hikma Farmaceutica
ndc-id:
ndc-product-code:62778-059
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-12-03
ended-marketing-on:2010-12-03
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA077966
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Hikma Farmaceutica
ndc-id:
ndc-product-code:62778-060
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-12-03
ended-marketing-on:2010-12-03
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA077966
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Hikma Farmaceutica
ndc-id:
ndc-product-code:62778-061
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-12-03
ended-marketing-on:2010-12-03
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA077966
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Bedford Pharmaceuticals
ndc-id:
ndc-product-code:55390-021
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-05-27
ended-marketing-on:2015-05-31
dosage-form:Injection
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA075660
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Bedford Pharmaceuticals
ndc-id:
ndc-product-code:55390-020
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-05-27
ended-marketing-on:2012-02-29
dosage-form:Injection
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA075660
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Bedford Pharmaceuticals
ndc-id:
ndc-product-code:55390-019
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-05-27
ended-marketing-on:2012-05-31
dosage-form:Injection
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA075660
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Bedford Pharmaceuticals
ndc-id:
ndc-product-code:55390-076
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-05-27
ended-marketing-on:2012-02-29
dosage-form:Injection
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA075660
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Bedford Pharmaceuticals
ndc-id:
ndc-product-code:55390-075
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-05-27
ended-marketing-on:2012-02-29
dosage-form:Injection
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA075660
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Bedford Pharmaceuticals
ndc-id:
ndc-product-code:55390-074
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-05-27
ended-marketing-on:2011-10-31
dosage-form:Injection
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA075660
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Baxter Laboratories
ndc-id:
ndc-product-code:10019-070
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-05-28
ended-marketing-on:2013-06-30
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA075530
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Gland Pharma Limited
ndc-id:
ndc-product-code:68083-318
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-07-28
ended-marketing-on:
dosage-form:Injection
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA077190
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Hospira, Inc.
ndc-id:
ndc-product-code:0409-2775
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2006-07-17
ended-marketing-on:2006-07-17
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:West-Ward Pharmaceuticals Corp
ndc-id:
ndc-product-code:0143-9326
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-12-03
ended-marketing-on:
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA077966
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:West-Ward Pharmaceuticals Corp
ndc-id:
ndc-product-code:0143-9710
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-12-03
ended-marketing-on:
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA077966
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:West-Ward Pharmaceuticals Corp
ndc-id:
ndc-product-code:0143-9709
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-12-03
ended-marketing-on:
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA077966
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:West-Ward Pharmaceuticals Corp
ndc-id:
ndc-product-code:0143-9708
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-12-03
ended-marketing-on:
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA077966
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Hospira, Inc.
ndc-id:
ndc-product-code:0409-0212
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-03-31
ended-marketing-on:
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA203280
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Fresenius Kabi USA, LLC
ndc-id:
ndc-product-code:63323-617
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-08-01
ended-marketing-on:
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA075936
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Meitheal Pharmaceuticals Inc.
ndc-id:
ndc-product-code:71288-200
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-03-24
ended-marketing-on:
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA211671
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Hospira, Inc.
ndc-id:
ndc-product-code:0409-2776
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2005-06-24
ended-marketing-on:
dosage-form:Injection, solution
strength:200 ug/1mL
route:Intravenous
fda-application-number:ANDA075885
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:AuroMedics Pharma LLC
ndc-id:
ndc-product-code:55150-287
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-09-03
ended-marketing-on:
dosage-form:Injection, solution
strength:0.2 mg/1mL
route:Intravenous
fda-application-number:ANDA209666
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:AuroMedics Pharma LLC
ndc-id:
ndc-product-code:55150-288
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-09-03
ended-marketing-on:
dosage-form:Injection, solution
strength:0.2 mg/1mL
route:Intravenous
fda-application-number:ANDA209666
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Hikma Pharmaceuticals USA Inc.
ndc-id:
ndc-product-code:0143-9374
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-12-03
ended-marketing-on:
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA077966
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate
labeller:Hikma Pharmaceuticals USA Inc.
ndc-id:
ndc-product-code:0143-9373
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-12-03
ended-marketing-on:
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:ANDA077966
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate in Dextrose
labeller:B. Braun Medical Inc.
ndc-id:
ndc-product-code:0264-3000
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-10-29
ended-marketing-on:
dosage-form:Injection
strength:
route:Intravenous
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate in Dextrose
labeller:Bedford Pharmaceuticals
ndc-id:
ndc-product-code:55390-078
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-02-16
ended-marketing-on:2013-10-31
dosage-form:Injection, solution
strength:200 ug/1mL
route:Intravenous
fda-application-number:ANDA078113
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate in Dextrose
labeller:Bedford Pharmaceuticals
ndc-id:
ndc-product-code:55390-079
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-02-16
ended-marketing-on:2013-10-31
dosage-form:Injection, solution
strength:200 ug/1mL
route:Intravenous
fda-application-number:ANDA078113
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate in Dextrose
labeller:Baxter Healthcare Corporation
ndc-id:
ndc-product-code:0338-0611
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2006-07-27
ended-marketing-on:2006-07-27
dosage-form:Injection
strength:200 ug/1mL
route:Intravenous
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate in Dextrose
labeller:West-Ward Pharmaceuticals Corp
ndc-id:
ndc-product-code:0143-9719
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-01-21
ended-marketing-on:
dosage-form:Injection, solution
strength:200 ug/1mL
route:Intravenous
fda-application-number:ANDA090038
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate in Dextrose
labeller:West-Ward Pharmaceuticals Corp
ndc-id:
ndc-product-code:0143-9718
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-01-21
ended-marketing-on:
dosage-form:Injection, solution
strength:200 ug/1mL
route:Intravenous
fda-application-number:ANDA090038
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate in Dextrose
labeller:Baxter Healthcare Corporation
ndc-id:
ndc-product-code:0338-6010
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-05-28
ended-marketing-on:
dosage-form:Injection, solution
strength:0.2 mg/1mL
route:Intravenous
fda-application-number:ANDA075834
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate in Dextrose
labeller:Baxter Healthcare Corporation
ndc-id:
ndc-product-code:0338-6011
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-05-28
ended-marketing-on:
dosage-form:Injection, solution
strength:0.2 mg/1mL
route:Intravenous
fda-application-number:ANDA075834
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate in Dextrose
labeller:Gland Pharma Limited
ndc-id:
ndc-product-code:68083-410
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-07-16
ended-marketing-on:
dosage-form:Injection, solution
strength:0.2 mg/1mL
route:Intravenous
fda-application-number:ANDA213585
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate in Dextrose
labeller:Gland Pharma Limited
ndc-id:
ndc-product-code:68083-411
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-07-16
ended-marketing-on:
dosage-form:Injection, solution
strength:0.2 mg/1mL
route:Intravenous
fda-application-number:ANDA213585
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Milrinone Lactate Injection
labeller:Sandoz Canada Incorporated
ndc-id:
ndc-product-code:
dpd-id:02244854
ema-product-code:
ema-ma-number:
started-marketing-on:2003-06-25
ended-marketing-on:
dosage-form:Solution
strength:
route:Intravenous
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Milrinone Lactate Injection
labeller:Strides Pharma Canada Inc
ndc-id:
ndc-product-code:
dpd-id:02383519
ema-product-code:
ema-ma-number:
started-marketing-on:
ended-marketing-on:
dosage-form:Solution
strength:
route:Intravenous
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Milrinone Lactate Injection
labeller:Sterimax Inc
ndc-id:
ndc-product-code:
dpd-id:02447908
ema-product-code:
ema-ma-number:
started-marketing-on:
ended-marketing-on:
dosage-form:Solution
strength:
route:Intravenous
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Milrinone Lactate Injection
labeller:Auro Pharma Inc
ndc-id:
ndc-product-code:
dpd-id:02470047
ema-product-code:
ema-ma-number:
started-marketing-on:2018-12-24
ended-marketing-on:
dosage-form:Solution
strength:
route:Intravenous
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Milrinone Lactate Injection, USP
labeller:Fresenius Kabi
ndc-id:
ndc-product-code:
dpd-id:02244622
ema-product-code:
ema-ma-number:
started-marketing-on:2003-07-03
ended-marketing-on:
dosage-form:Solution
strength:
route:Intravenous
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Primacor
labeller:Sanofi-Synthelabo Inc.
ndc-id:
ndc-product-code:0024-1200
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2006-05-10
ended-marketing-on:2018-10-11
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intravenous
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Primacor
labeller:sanofi-aventis U.S. LLC
ndc-id:
ndc-product-code:0024-1203
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1987-12-31
ended-marketing-on:2009-09-30
dosage-form:Injection, solution
strength:200 ug/1mL
route:Intravenous
fda-application-number:NDA020343
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Primacor Injection 1mg/ml
labeller:Sanofi Synthelabo
ndc-id:
ndc-product-code:
dpd-id:02006391
ema-product-code:
ema-ma-number:
started-marketing-on:1995-12-31
ended-marketing-on:2005-08-01
dosage-form:Solution
strength:
route:Intravenous
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD

混合物

name:Primacor
ingredients:Milrinone
name:Milrinone Lactate in Dextrose
ingredients:D-glucose + Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone lactate
ingredients:Milrinone
name:Milrinone lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate in Dextrose
ingredients:Milrinone
name:Milrinone Lactate in Dextrose
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate in Dextrose
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate in Dextrose
ingredients:Milrinone
name:Milrinone Lactate in Dextrose
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate in Dextrose
ingredients:Milrinone
name:Milrinone Lactate in Dextrose
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Primacor
ingredients:Milrinone
name:Milrinone Lactate in Dextrose
ingredients:Milrinone
name:Milrinone Lactate in Dextrose
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate
ingredients:Milrinone
name:Milrinone Lactate Injection
ingredients:Milrinone
name:Primacor Injection 1mg/ml
ingredients:Milrinone
name:Milrinone Injection
ingredients:Milrinone
name:Apo-milrinone Injectable
ingredients:Milrinone
name:Milrinone Lactate Injection
ingredients:Milrinone
name:Milrinone Lactate Injection
ingredients:Milrinone
name:Milrinone Lactate Injection, USP
ingredients:Milrinone
name:Milrinone Lactate Injection
ingredients:Milrinone

包装者

name:Alchymars SPA
url:
name:Apotex Inc.
url:http://www.apotex.com
name:APP Pharmaceuticals
url:http://www.apppharma.com
name:B. Braun Melsungen AG
url:http://www.bbraun.com
name:Baxter International Inc.
url:http://www.baxter.com
name:Bedford Labs
url:http://www.bedfordlabs.com
name:Ben Venue Laboratories Inc.
url:http://www.benvenue.com
name:Bioniche Pharma
url:http://www.bionichepharmausa.com
name:Cardinal Health
url:http://www.cardinal.com
name:Hospira Inc.
url:http://www.hospira.com
name:Sanofi-Aventis Inc.
url:http://www.sanofi-aventis.com
name:Teva Pharmaceutical Industries Ltd.
url:http://www.tevapharm.com

生产者

generic:是; url:; name;App pharmaceuticals llc
generic:是; url:; name;Baxter healthcare corp anesthesia and critical care
generic:是; url:; name;Baxter healthcare corp anesthesia critical care
generic:是; url:; name;Bedford laboratories div ben venue laboratories inc
generic:是; url:; name;Bioniche pharma usa llc
generic:是; url:; name;Claris lifesciences ltd
generic:是; url:; name;Gland pharma ltd
generic:是; url:; name;Hospira inc
generic:是; url:; name;International medicated systems ltd
generic:否; url:; name;B braun medical inc
generic:否; url:; name;Baxter healthcare corp
generic:否; url:; name;Bedford laboratories
generic:否; url:; name;Hikma farmaceutica (portugal) sa
generic:否; url:; name;Sanofi aventis us llc

价格

Milrinone lact 10 mg/10 ml vial
1.31(单位：USD）
ml
Milrinone lact 20 mg/20 ml vial
1.44(单位：USD）
ml
Milrinone-d5w 20 mg/100 ml
1.45(单位：USD）
ml
Primacor 0.2 mg/ml-d5w 100 ml
1.6(单位：USD）
ml

受影响的生物体

Humans and other mammals

剂量

form:Injection, solution, concentrate
route:Intravenous
strength:1 mg/ml
form:Injection, solution
route:Parenteral
strength:10 mg
form:Solution
route:Intravenous
strength:10 mg/10ml
form:Injection, solution
route:Intravenous
strength:1 mg/ml
form:Injection, solution
route:Parenteral
strength:1 mg/ml
form:Solution
route:Intravenous
strength:20 mg
form:Solution
route:Intravenous
strength:0.01 g
form:Solution
route:Intravenous
strength:1 mg
form:Injection
route:Intravenous
strength:1 mg/1mL
form:Injection
route:Intravenous
strength:20 mg/100mL
form:Injection, solution
route:Intravenous
strength:200 ug/1mL
form:Injection
route:Intravenous
strength:
form:Injection
route:Intravenous
strength:200 ug/1mL
form:Injection, solution
route:Intravenous
strength:0.2 mg/1mL
form:Solution
route:Intravenous
strength:
form:Tablet
route:Oral
strength:10 mg
form:Solution
route:Intravenous
strength:10 mg
form:Injection, solution
route:Intravenous
strength:1 mg/1mL
form:Injection, solution
route:Intravenous
strength:10 mg/10mL
form:Injection
route:Intravenous
strength:1 MG/ML

atc代码

Phosphodiesterase inhibitors
CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
CARDIAC THERAPY
CARDIOVASCULAR SYSTEM

fda标签

//s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00235.pdf?1265922798

化学品安全技术说明书

//s3-us-west-2.amazonaws.com/drugbank/msds/DB00235.pdf?1265922738

专利

食物相互作用

药物相互作用

DB00770
The risk or severity of hypotension and priapism can be increased when Milrinone is combined with Alprostadil.
DB01612
The risk or severity of hypotension can be increased when Milrinone is combined with Amyl Nitrite.
DB04884
The risk or severity of orthostatic hypotension can be increased when Dapoxetine is combined with Milrinone.
DB08931
Milrinone may increase the hypotensive activities of Riociguat.
DB00261
The risk or severity of congestive heart failure, bleeding, hypotension, and Tachycardia can be increased when Milrinone is combined with Anagrelide.
DB01166
The risk or severity of congestive heart failure, bleeding, hypotension, and Tachycardia can be increased when Milrinone is combined with Cilostazol.
DB01427
The risk or severity of congestive heart failure, bleeding, hypotension, and Tachycardia can be increased when Milrinone is combined with Amrinone.
DB04880
The risk or severity of congestive heart failure, bleeding, hypotension, and Tachycardia can be increased when Milrinone is combined with Enoximone.
DB00360
Sapropterin may increase the hypotensive activities of Milrinone.
DB00898
Ethanol may increase the hypotensive activities of Milrinone.
DB00177
Milrinone may increase the antihypertensive activities of Valsartan.
DB00178
Milrinone may increase the antihypertensive activities of Ramipril.
DB00187
Milrinone may increase the antihypertensive activities of Esmolol.
DB00195
Milrinone may increase the antihypertensive activities of Betaxolol.
DB00206
Milrinone may increase the antihypertensive activities of Reserpine.
DB00212
Milrinone may increase the antihypertensive activities of Remikiren.
DB00217
Milrinone may increase the antihypertensive activities of Bethanidine.
DB00226
Milrinone may increase the antihypertensive activities of Guanadrel.
DB00264
Milrinone may increase the antihypertensive activities of Metoprolol.
DB00270
Milrinone may increase the antihypertensive activities of Isradipine.
DB00275
Milrinone may increase the antihypertensive activities of Olmesartan.
DB00325
Milrinone may increase the antihypertensive activities of Nitroprusside.
DB00335
Milrinone may increase the antihypertensive activities of Atenolol.
DB00343
Milrinone may increase the antihypertensive activities of Diltiazem.
DB00350
Milrinone may increase the antihypertensive activities of Minoxidil.
DB00373
Milrinone may increase the antihypertensive activities of Timolol.
DB00374
Milrinone may increase the antihypertensive activities of Treprostinil.
DB00381
Milrinone may increase the antihypertensive activities of Amlodipine.
DB00393
Milrinone may increase the antihypertensive activities of Nimodipine.
DB00401
Milrinone may increase the antihypertensive activities of Nisoldipine.
DB00492
Milrinone may increase the antihypertensive activities of Fosinopril.
DB00519
Milrinone may increase the antihypertensive activities of Trandolapril.
DB00528
Milrinone may increase the antihypertensive activities of Lercanidipine.
DB00542
Milrinone may increase the antihypertensive activities of Benazepril.
DB00559
Milrinone may increase the antihypertensive activities of Bosentan.
DB00571
Milrinone may increase the antihypertensive activities of Propranolol.
DB00575
Milrinone may increase the antihypertensive activities of Clonidine.
DB00584
Milrinone may increase the antihypertensive activities of Enalapril.
DB00612
Milrinone may increase the antihypertensive activities of Bisoprolol.
DB00616
Milrinone may increase the antihypertensive activities of Candoxatril.
DB00629
Milrinone may increase the antihypertensive activities of Guanabenz.
DB00657
Milrinone may increase the antihypertensive activities of Mecamylamine.
DB00678
Milrinone may increase the antihypertensive activities of Losartan.
DB00691
Milrinone may increase the antihypertensive activities of Moexipril.
DB00722
Milrinone may increase the antihypertensive activities of Lisinopril.
DB00765
Milrinone may increase the antihypertensive activities of Metyrosine.
DB00785
Milrinone may increase the antihypertensive activities of Cryptenamine.
DB00790
Milrinone may increase the antihypertensive activities of Perindopril.
DB00796
Milrinone may increase the antihypertensive activities of Candesartan cilexetil.
DB00800
Milrinone may increase the antihypertensive activities of Fenoldopam.
DB00866
Milrinone may increase the antihypertensive activities of Alprenolol.
DB00876
Milrinone may increase the antihypertensive activities of Eprosartan.
DB00881
Milrinone may increase the antihypertensive activities of Quinapril.
DB00886
Milrinone may increase the antihypertensive activities of Omapatrilat.
DB00960
Milrinone may increase the antihypertensive activities of Pindolol.
DB00966
Milrinone may increase the antihypertensive activities of Telmisartan.
DB00968
Milrinone may increase the antihypertensive activities of Methyldopa.
DB01018
Milrinone may increase the antihypertensive activities of Guanfacine.
DB01023
Milrinone may increase the antihypertensive activities of Felodipine.
DB01029
Milrinone may increase the antihypertensive activities of Irbesartan.
DB01054
Milrinone may increase the antihypertensive activities of Nitrendipine.
DB01089
Milrinone may increase the antihypertensive activities of Deserpidine.
DB01090
Milrinone may increase the antihypertensive activities of Pentolinium.
DB01116
Milrinone may increase the antihypertensive activities of Trimethaphan.
DB01158
Milrinone may increase the antihypertensive activities of Bretylium.
DB01170
Milrinone may increase the antihypertensive activities of Guanethidine.
DB01180
Milrinone may increase the antihypertensive activities of Rescinnamine.
DB01193
Milrinone may increase the antihypertensive activities of Acebutolol.
DB01197
Milrinone may increase the antihypertensive activities of Captopril.
DB01203
Milrinone may increase the antihypertensive activities of Nadolol.
DB01240
Milrinone may increase the antihypertensive activities of Epoprostenol.
DB01244
Milrinone may increase the antihypertensive activities of Bepridil.
DB01275
Milrinone may increase the antihypertensive activities of Hydralazine.
DB01297
Milrinone may increase the antihypertensive activities of Practolol.
DB01340
Milrinone may increase the antihypertensive activities of Cilazapril.
DB01347
Milrinone may increase the antihypertensive activities of Saprisartan.
DB01348
Milrinone may increase the antihypertensive activities of Spirapril.
DB01359
Milrinone may increase the antihypertensive activities of Penbutolol.
DB01388
Milrinone may increase the antihypertensive activities of Mibefradil.
DB01580
Milrinone may increase the antihypertensive activities of Oxprenolol.
DB01626
Milrinone may increase the antihypertensive activities of Pargyline.
DB03322
Milrinone may increase the antihypertensive activities of Dexpropranolol.
DB04840
Milrinone may increase the antihypertensive activities of Debrisoquine.
DB04846
Milrinone may increase the antihypertensive activities of Celiprolol.
DB04861
Milrinone may increase the antihypertensive activities of Nebivolol.
DB04948
Milrinone may increase the antihypertensive activities of Lofexidine.
DB06268
Milrinone may increase the antihypertensive activities of Sitaxentan.
DB06403
Milrinone may increase the antihypertensive activities of Ambrisentan.
DB06445
Milrinone may increase the antihypertensive activities of Diethylnorspermine.
DB06712
Milrinone may increase the antihypertensive activities of Nilvadipine.
DB06762
Milrinone may increase the antihypertensive activities of Pinacidil.
DB07767
Milrinone may increase the antihypertensive activities of Ferulic acid.
DB08808
Milrinone may increase the antihypertensive activities of Bupranolol.
DB08836
Milrinone may increase the antihypertensive activities of Temocapril.
DB08932
Milrinone may increase the antihypertensive activities of Macitentan.
DB08952
Milrinone may increase the antihypertensive activities of Indenolol.
DB08960
Milrinone may increase the antihypertensive activities of Hexamethonium.
DB09026
Milrinone may increase the antihypertensive activities of Aliskiren.
DB09236
Milrinone may increase the antihypertensive activities of Lacidipine.
DB09238
Milrinone may increase the antihypertensive activities of Manidipine.
DB09242
Milrinone may increase the antihypertensive activities of Moxonidine.
DB09363
Milrinone may increase the antihypertensive activities of Rauwolfia serpentina root.
DB09477
Milrinone may increase the antihypertensive activities of Enalaprilat.
DB11362
Milrinone may increase the antihypertensive activities of Selexipag.
DB11720
Milrinone may increase the antihypertensive activities of Angiotensin 1-7.
DB11738
Milrinone may increase the antihypertensive activities of Rilmenidine.
DB11770
Milrinone may increase the antihypertensive activities of Talinolol.
DB11783
Milrinone may increase the antihypertensive activities of Imidapril.
DB12054
Milrinone may increase the antihypertensive activities of BQ-123.
DB12092
Milrinone may increase the antihypertensive activities of Naftopidil.
DB12093
Milrinone may increase the antihypertensive activities of Tetrahydropalmatine.
DB12212
Milrinone may increase the antihypertensive activities of Landiolol.
DB12465
Milrinone may increase the antihypertensive activities of Ketanserin.
DB12945
Milrinone may increase the antihypertensive activities of Dihydralazine.
DB13166
Milrinone may increase the antihypertensive activities of Zofenopril.
DB13211
Milrinone may increase the antihypertensive activities of Guanoxan.
DB13312
Milrinone may increase the antihypertensive activities of Delapril.
DB13374
Milrinone may increase the antihypertensive activities of Vincamine.
DB13400
Milrinone may increase the antihypertensive activities of Linsidomine.
DB13410
Milrinone may increase the antihypertensive activities of Guanoxabenz.
DB13429
Milrinone may increase the antihypertensive activities of Tolonidine.
DB13435
Milrinone may increase the antihypertensive activities of Endralazine.
DB13443
Milrinone may increase the antihypertensive activities of Esatenolol.
DB13452
Milrinone may increase the antihypertensive activities of Cadralazine.
DB13508
Milrinone may increase the antihypertensive activities of Cloranolol.
DB13575
Milrinone may increase the antihypertensive activities of Bietaserpine.
DB13604
Milrinone may increase the antihypertensive activities of Guanazodine.
DB13631
Milrinone may increase the antihypertensive activities of Methoserpidine.
DB13757
Milrinone may increase the antihypertensive activities of Epanolol.
DB13779
Milrinone may increase the antihypertensive activities of Guanoclor.
DB13919
Milrinone may increase the antihypertensive activities of Candesartan.
DB14068
Milrinone may increase the antihypertensive activities of Dexniguldipine.
DB14094
Milrinone may increase the antihypertensive activities of Tocopherylquinone.
DB14125
Milrinone may increase the antihypertensive activities of Benazeprilat.
DB14207
Milrinone may increase the antihypertensive activities of Fosinoprilat.
DB14208
Milrinone may increase the antihypertensive activities of Ramiprilat.
DB14213
Milrinone may increase the antihypertensive activities of Perindoprilat.
DB14217
Milrinone may increase the antihypertensive activities of Quinaprilat.
DB09237
Milrinone may increase the antihypertensive activities of Levamlodipine.
DB09282
Molsidomine may increase the hypotensive activities of Milrinone.
DB00727
The risk or severity of hypotension can be increased when Milrinone is combined with Nitroglycerin.
DB00883
The risk or severity of hypotension can be increased when Milrinone is combined with Isosorbide dinitrate.
DB01613
The risk or severity of hypotension can be increased when Milrinone is combined with Erythrityl tetranitrate.
DB06154
The risk or severity of hypotension can be increased when Milrinone is combined with Pentaerythritol tetranitrate.
DB09401
The risk or severity of hypotension can be increased when Milrinone is combined with Isosorbide.
DB13255
The risk or severity of hypotension can be increased when Milrinone is combined with Propatyl nitrate.
DB13408
The risk or severity of hypotension can be increased when Milrinone is combined with Methylpropylpropanediol dinitrate.
DB13637
The risk or severity of hypotension can be increased when Milrinone is combined with Tenitramine.
DB13719
The risk or severity of hypotension can be increased when Milrinone is combined with Trolnitrate.
DB14049
The risk or severity of hypotension can be increased when Milrinone is combined with Nitrate.
DB00203
The risk or severity of adverse effects can be increased when Sildenafil is combined with Milrinone.
DB00806
The risk or severity of adverse effects can be increased when Milrinone is combined with Pentoxifylline.
DB00820
The risk or severity of adverse effects can be increased when Milrinone is combined with Tadalafil.
DB00862
The risk or severity of adverse effects can be increased when Milrinone is combined with Vardenafil.
DB00975
The risk or severity of adverse effects can be increased when Milrinone is combined with Dipyridamole.
DB05266
The risk or severity of adverse effects can be increased when Milrinone is combined with Ibudilast.
DB06237
The risk or severity of adverse effects can be increased when Milrinone is combined with Avanafil.
DB06267
The risk or severity of adverse effects can be increased when Milrinone is combined with Udenafil.
DB09273
The risk or severity of adverse effects can be increased when Milrinone is combined with Doxofylline.
DB11792
The risk or severity of adverse effects can be increased when Milrinone is combined with Mirodenafil.
DB12010
The risk or severity of adverse effects can be increased when Milrinone is combined with Fostamatinib.
DB00457
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Prazosin.
DB00598
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Labetalol.
DB00622
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Nicardipine.
DB00692
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Phentolamine.
DB00797
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Tolazoline.
DB00925
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Phenoxybenzamine.
DB01136
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Carvedilol.
DB01162
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Terazosin.
DB01295
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Bevantolol.
DB08950
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Indoramin.
DB09206
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Trimazosin.
DB09239
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Niguldipine.
DB12661
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Urapidil.
DB00246
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Ziprasidone.
DB00320
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Dihydroergotamine.
DB00334
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Olanzapine.
DB00346
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Alfuzosin.
DB00363
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Clozapine.
DB00420
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Promazine.
DB00450
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Droperidol.
DB00477
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Chlorpromazine.
DB00540
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Nortriptyline.
DB00543
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Amoxapine.
DB00656
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Trazodone.
DB00661
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Verapamil.
DB00679
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Thioridazine.
DB00696
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Ergotamine.
DB00699
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Nicergoline.
DB00706
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Tamsulosin.
DB00726
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Trimipramine.
DB00734
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Risperidone.
DB00777
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Propiomazine.
DB00831
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Trifluoperazine.
DB00875
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Flupentixol.
DB01149
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Nefazodone.
DB01200
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Bromocriptine.
DB01224
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Quetiapine.
DB01238
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Aripiprazole.
DB01267
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Paliperidone.
DB01403
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Methotrimeprazine.
DB01608
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Periciazine.
DB01614
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Acepromazine.
DB01622
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Thioproperazine.
DB01624
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Zuclopenthixol.
DB04855
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Dronedarone.
DB04946
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Iloperidone.
DB06153
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Pizotifen.
DB06207
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Silodosin.
DB06216
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Asenapine.
DB09128
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Brexpiprazole.
DB12230
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Bunazosin.
DB12278
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Propiverine.
DB12752
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Bucindolol.
DB14185
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Aripiprazole lauroxil.
DB00321
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Amitriptyline.
DB00458
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Imipramine.
DB01142
The risk or severity of hypotension, dyspepsia, and headache can be increased when Milrinone is combined with Doxepin.
DB13967
The therapeutic efficacy of Milrinone can be decreased when used in combination with Patent Blue.
DB00999
Milrinone may decrease the excretion rate of Hydrochlorothiazide which could result in a higher serum level.
DB00091
Cyclosporine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00159
Icosapent may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00229
Cefotiam may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00244
Mesalazine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00267
Cefmenoxime may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00274
Cefmetazole may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00282
Pamidronic acid may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00300
Tenofovir disoproxil may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00328
Indomethacin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00369
Cidofovir may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00384
Triamterene may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00430
Cefpiramide may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00438
Ceftazidime may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00447
Loracarbef may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00456
Cefalotin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00461
Nabumetone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00465
Ketorolac may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00469
Tenoxicam may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00482
Celecoxib may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00493
Cefotaxime may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00500
Tolmetin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00529
Foscarnet may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00533
Rofecoxib may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00554
Piroxicam may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00563
Methotrexate may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00567
Cephalexin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00573
Fenoprofen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00577
Valaciclovir may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00580
Valdecoxib may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00586
Diclofenac may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00605
Sulindac may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00626
Bacitracin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00681
Amphotericin B may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00689
Cephaloglycin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00712
Flurbiprofen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00718
Adefovir dipivoxil may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00738
Pentamidine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00742
Mannitol may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00749
Etodolac may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00784
Mefenamic acid may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00787
Acyclovir may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00788
Naproxen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00795
Sulfasalazine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00812
Phenylbutazone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00814
Meloxicam may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00821
Carprofen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00833
Cefaclor may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00861
Diflunisal may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00864
Tacrolimus may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00903
Etacrynic acid may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00923
Ceforanide may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00936
Salicylic acid may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00939
Meclofenamic acid may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00945
Acetylsalicylic acid may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00958
Carboplatin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00991
Oxaprozin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01009
Ketoprofen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01014
Balsalazide may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01050
Ibuprofen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01066
Cefditoren may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01072
Atazanavir may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01111
Colistimethate may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01112
Cefuroxime may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01139
Cefapirin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01140
Cefadroxil may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01150
Cefprozil may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01212
Ceftriaxone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01250
Olsalazine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01283
Lumiracoxib may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01326
Cefamandole may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01327
Cefazolin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01328
Cefonicid may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01329
Cefoperazone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01330
Cefotetan may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01331
Cefoxitin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01332
Ceftizoxime may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01333
Cefradine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01397
Magnesium salicylate may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01399
Salsalate may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01401
Choline magnesium trisalicylate may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01413
Cefepime may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01414
Cefacetrile may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01415
Ceftibuten may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01416
Cefpodoxime may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01419
Antrafenine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01424
Aminophenazone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01435
Antipyrine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01600
Tiaprofenic acid may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01628
Etoricoxib may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB02247
Hydrolyzed Cephalothin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB03450
Cephalothin Group may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB03585
Oxyphenbutazone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB04570
Latamoxef may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB04743
Nimesulide may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB04812
Benoxaprofen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB04817
Metamizole may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB04828
Zomepirac may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB04918
Ceftobiprole may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB05095
Cimicoxib may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB06590
Ceftaroline fosamil may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB06725
Lornoxicam may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB06736
Aceclofenac may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB06737
Zaltoprofen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB07402
Azapropazone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB08439
Parecoxib may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB08797
Salicylamide may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB08940
Kebuzone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB08942
Isoxicam may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB08951
Indoprofen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB08955
Ibuproxam may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB08976
Floctafenine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB08981
Fenbufen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB08984
Etofenamate may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB08991
Epirizole may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09008
Cefaloridine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09062
Cefminox may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09084
Benzydamine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09213
Dexibuprofen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09214
Dexketoprofen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09215
Droxicam may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09216
Tolfenamic acid may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09217
Firocoxib may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09218
Clonixin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09285
Morniflumate may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09288
Propacetamol may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09295
Talniflumate may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09299
Tenofovir alafenamide may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB11367
Cefroxadine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB11455
Robenacoxib may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB11466
Tepoxalin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB11518
Flunixin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB11935
Flomoxef may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB12151
Brincidofovir may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB12445
Nitroaspirin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB12545
Indobufen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13001
Tinoridine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13167
Alclofenac may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13217
Fentiazac may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13232
Suxibuzone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13266
Cefatrizine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13286
Bumadizone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13314
Alminoprofen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13371
Difenpiramide may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13407
Nifenazone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13432
Lonazolac may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13461
Cefcapene may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13470
Cefodizime may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13481
Tenidap may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13499
Cefsulodin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13504
Cefetamet may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13524
Propyphenazone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13527
Proglumetacin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13538
Guacetisal may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13544
Ethenzamide may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13612
Carbaspirin calcium may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13629
Mofebutazone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13638
Cefbuperazone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13649
Proquazone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13657
Benorilate may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13667
Cefozopran may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13682
Cefpirome may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13722
Pirprofen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13778
Cefazedone may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13783
Acemetacin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13821
Ceftezole may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13860
Imidazole salicylate may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13868
Adefovir may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB14059
SC-236 may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB14060
NS-398 may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB14126
Tenofovir may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB14713
Inotersen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01438
Phenazopyridine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB15066
Givosiran may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01356
Lithium cation may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB14507
Lithium citrate may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09212
Loxoprofen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00452
Framycetin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01421
Paromomycin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB04263
Geneticin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB04626
Apramycin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB04808
Neamine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB08437
Puromycin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB11512
Dihydrostreptomycin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB11520
Hygromycin B may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00007
Leuprolide may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00014
Goserelin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00017
Salmon calcitonin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00035
Desmopressin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00041
Aldesleukin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00080
Daptomycin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00081
Tositumomab may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00115
Cyanocobalamin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00158
Folic acid may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00165
Pyridoxine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00176
Fluvoxamine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00181
Baclofen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00182
Amphetamine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00185
Cevimeline may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00186
Lorazepam may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00190
Carbidopa may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00193
Tramadol may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00196
Fluconazole may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00198
Oseltamivir may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00200
Hydroxocobalamin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00208
Ticlopidine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00213
Pantoprazole may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00225
Gadodiamide may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00230
Pregabalin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00231
Temazepam may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00237
Milrinone may decrease the excretion rate of Butabarbital which could result in a higher serum level.
DB00243
Milrinone may decrease the excretion rate of Ranolazine which could result in a higher serum level.
DB00245
Milrinone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00254
Milrinone may decrease the excretion rate of Doxycycline which could result in a higher serum level.
DB00262
Milrinone may decrease the excretion rate of Carmustine which could result in a higher serum level.
DB00271
Milrinone may decrease the excretion rate of Diatrizoate which could result in a higher serum level.
DB00273
Milrinone may decrease the excretion rate of Topiramate which could result in a higher serum level.
DB00279
Milrinone may decrease the excretion rate of Liothyronine which could result in a higher serum level.
DB00280
Milrinone may decrease the excretion rate of Disopyramide which could result in a higher serum level.
DB00284
Milrinone may decrease the excretion rate of Acarbose which could result in a higher serum level.
DB00285
Milrinone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.
DB00286
Milrinone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
DB00289
Milrinone may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
DB00290
Milrinone may decrease the excretion rate of Bleomycin which could result in a higher serum level.
DB00292
Milrinone may decrease the excretion rate of Etomidate which could result in a higher serum level.
DB00294
Milrinone may decrease the excretion rate of Etonogestrel which could result in a higher serum level.
DB00296
Milrinone may decrease the excretion rate of Ropivacaine which could result in a higher serum level.
DB00303
Milrinone may decrease the excretion rate of Ertapenem which could result in a higher serum level.
DB00308
Milrinone may decrease the excretion rate of Ibutilide which could result in a higher serum level.
DB00312
Milrinone may decrease the excretion rate of Pentobarbital which could result in a higher serum level.
DB00316
Milrinone may decrease the excretion rate of Acetaminophen which could result in a higher serum level.
DB00319
Milrinone may decrease the excretion rate of Piperacillin which could result in a higher serum level.
DB00322
Milrinone may decrease the excretion rate of Floxuridine which could result in a higher serum level.
DB00323
Milrinone may decrease the excretion rate of Tolcapone which could result in a higher serum level.
DB00327
Milrinone may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
DB00330
Milrinone may decrease the excretion rate of Ethambutol which could result in a higher serum level.
DB00331
Milrinone may decrease the excretion rate of Metformin which could result in a higher serum level.
DB00333
Milrinone may decrease the excretion rate of Methadone which could result in a higher serum level.
DB00339
Milrinone may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
DB00341
Milrinone may decrease the excretion rate of Cetirizine which could result in a higher serum level.
DB00349
Milrinone may decrease the excretion rate of Clobazam which could result in a higher serum level.
DB00351
Milrinone may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.
DB00355
Milrinone may decrease the excretion rate of Aztreonam which could result in a higher serum level.
DB00356
Milrinone may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.
DB00359
Milrinone may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
DB00364
Milrinone may decrease the excretion rate of Sucralfate which could result in a higher serum level.
DB00372
Milrinone may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.
DB00377
Milrinone may decrease the excretion rate of Palonosetron which could result in a higher serum level.
DB00380
Milrinone may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
DB00398
Milrinone may decrease the excretion rate of Sorafenib which could result in a higher serum level.
DB00402
Milrinone may decrease the excretion rate of Eszopiclone which could result in a higher serum level.
DB00404
Milrinone may decrease the excretion rate of Alprazolam which could result in a higher serum level.
DB00412
Milrinone may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
DB00413
Milrinone may decrease the excretion rate of Pramipexole which could result in a higher serum level.
DB00415
Milrinone may decrease the excretion rate of Ampicillin which could result in a higher serum level.
DB00418
Milrinone may decrease the excretion rate of Secobarbital which could result in a higher serum level.
DB00422
Milrinone may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
DB00432
Milrinone may decrease the excretion rate of Trifluridine which could result in a higher serum level.
DB00435
Milrinone may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.
DB00437
Milrinone may decrease the excretion rate of Allopurinol which could result in a higher serum level.
DB00440
Milrinone may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
DB00441
Milrinone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
DB00476
Milrinone may decrease the excretion rate of Duloxetine which could result in a higher serum level.
DB00480
Milrinone may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
DB00490
Milrinone may decrease the excretion rate of Buspirone which could result in a higher serum level.
DB00499
Milrinone may decrease the excretion rate of Flutamide which could result in a higher serum level.
DB00501
Milrinone may decrease the excretion rate of Cimetidine which could result in a higher serum level.
DB00502
Milrinone may decrease the excretion rate of Haloperidol which could result in a higher serum level.
DB00535
Milrinone may decrease the excretion rate of Cefdinir which could result in a higher serum level.
DB00537
Milrinone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
DB00548
Milrinone may decrease the excretion rate of Azelaic acid which could result in a higher serum level.
DB00553
Milrinone may decrease the excretion rate of Methoxsalen which could result in a higher serum level.
DB00555
Milrinone may decrease the excretion rate of Lamotrigine which could result in a higher serum level.
DB00558
Milrinone may decrease the excretion rate of Zanamivir which could result in a higher serum level.
DB00569
Milrinone may decrease the excretion rate of Fondaparinux which could result in a higher serum level.
DB00583
Milrinone may decrease the excretion rate of Levocarnitine which could result in a higher serum level.
DB00591
Milrinone may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.
DB00597
Milrinone may decrease the excretion rate of Gadoteridol which could result in a higher serum level.
DB00603
Milrinone may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.
DB00608
Milrinone may decrease the excretion rate of Chloroquine which could result in a higher serum level.
DB00624
Milrinone may decrease the excretion rate of Testosterone which could result in a higher serum level.
DB00628
Milrinone may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
DB00631
Milrinone may decrease the excretion rate of Clofarabine which could result in a higher serum level.
DB00633
Milrinone may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.
DB00635
Milrinone may decrease the excretion rate of Prednisone which could result in a higher serum level.
DB00651
Milrinone may decrease the excretion rate of Dyphylline which could result in a higher serum level.
DB00660
Milrinone may decrease the excretion rate of Metaxalone which could result in a higher serum level.
DB00665
Milrinone may decrease the excretion rate of Nilutamide which could result in a higher serum level.
DB00669
Milrinone may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
DB00672
Milrinone may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.
DB00683
Milrinone may decrease the excretion rate of Midazolam which could result in a higher serum level.
DB00688
Milrinone may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
DB00690
Milrinone may decrease the excretion rate of Flurazepam which could result in a higher serum level.
DB00698
Milrinone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
DB00709
Milrinone may decrease the excretion rate of Lamivudine which could result in a higher serum level.
DB00713
Milrinone may decrease the excretion rate of Oxacillin which could result in a higher serum level.
DB00716
Milrinone may decrease the excretion rate of Nedocromil which could result in a higher serum level.
DB00730
Milrinone may decrease the excretion rate of Thiabendazole which could result in a higher serum level.
DB00731
Milrinone may decrease the excretion rate of Nateglinide which could result in a higher serum level.
DB00733
Milrinone may decrease the excretion rate of Pralidoxime which could result in a higher serum level.
DB00743
Milrinone may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.
DB00759
Milrinone may decrease the excretion rate of Tetracycline which could result in a higher serum level.
DB00760
Milrinone may decrease the excretion rate of Meropenem which could result in a higher serum level.
DB00761
Milrinone may decrease the excretion rate of Potassium chloride which could result in a higher serum level.
DB00763
Milrinone may decrease the excretion rate of Methimazole which could result in a higher serum level.
DB00775
Milrinone may decrease the excretion rate of Tirofiban which could result in a higher serum level.
DB00780
Milrinone may decrease the excretion rate of Phenelzine which could result in a higher serum level.
DB00782
Milrinone may decrease the excretion rate of Propantheline which could result in a higher serum level.
DB00783
Milrinone may decrease the excretion rate of Estradiol which could result in a higher serum level.
DB00789
Milrinone may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.
DB00804
Milrinone may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
DB00811
Milrinone may decrease the excretion rate of Ribavirin which could result in a higher serum level.
DB00828
Milrinone may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
DB00829
Milrinone may decrease the excretion rate of Diazepam which could result in a higher serum level.
DB00839
Milrinone may decrease the excretion rate of Tolazamide which could result in a higher serum level.
DB00841
Milrinone may decrease the excretion rate of Dobutamine which could result in a higher serum level.
DB00842
Milrinone may decrease the excretion rate of Oxazepam which could result in a higher serum level.
DB00851
Milrinone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
DB00853
Milrinone may decrease the excretion rate of Temozolomide which could result in a higher serum level.
DB00863
Milrinone may decrease the excretion rate of Ranitidine which could result in a higher serum level.
DB00871
Milrinone may decrease the excretion rate of Terbutaline which could result in a higher serum level.
DB00894
Milrinone may decrease the excretion rate of Testolactone which could result in a higher serum level.
DB00897
Milrinone may decrease the excretion rate of Triazolam which could result in a higher serum level.
DB00900
Milrinone may decrease the excretion rate of Didanosine which could result in a higher serum level.
DB00911
Milrinone may decrease the excretion rate of Tinidazole which could result in a higher serum level.
DB00915
Milrinone may decrease the excretion rate of Amantadine which could result in a higher serum level.
DB00918
Milrinone may decrease the excretion rate of Almotriptan which could result in a higher serum level.
DB00928
Milrinone may decrease the excretion rate of Azacitidine which could result in a higher serum level.
DB00934
Milrinone may decrease the excretion rate of Maprotiline which could result in a higher serum level.
DB00951
Milrinone may decrease the excretion rate of Isoniazid which could result in a higher serum level.
DB00953
Milrinone may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
DB00961
Milrinone may decrease the excretion rate of Mepivacaine which could result in a higher serum level.
DB00962
Milrinone may decrease the excretion rate of Zaleplon which could result in a higher serum level.
DB00980
Milrinone may decrease the excretion rate of Ramelteon which could result in a higher serum level.
DB00988
Milrinone may decrease the excretion rate of Dopamine which could result in a higher serum level.
DB00993
Milrinone may decrease the excretion rate of Azathioprine which could result in a higher serum level.
DB00995
Milrinone may decrease the excretion rate of Auranofin which could result in a higher serum level.
DB01001
Milrinone may decrease the excretion rate of Salbutamol which could result in a higher serum level.
DB01002
Milrinone may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.
DB01004
Milrinone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
DB01010
Milrinone may decrease the excretion rate of Edrophonium which could result in a higher serum level.
DB01011
Milrinone may decrease the excretion rate of Metyrapone which could result in a higher serum level.
DB01015
Milrinone may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.
DB01022
Milrinone may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
DB01024
Milrinone may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
DB01030
Milrinone may decrease the excretion rate of Topotecan which could result in a higher serum level.
DB01032
Milrinone may decrease the excretion rate of Probenecid which could result in a higher serum level.
DB01036
Milrinone may decrease the excretion rate of Tolterodine which could result in a higher serum level.
DB01039
Milrinone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
DB01043
Milrinone may decrease the excretion rate of Memantine which could result in a higher serum level.
DB01046
Milrinone may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
DB01048
Milrinone may decrease the excretion rate of Abacavir which could result in a higher serum level.
DB01060
Milrinone may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
DB01067
Milrinone may decrease the excretion rate of Glipizide which could result in a higher serum level.
DB01068
Milrinone may decrease the excretion rate of Clonazepam which could result in a higher serum level.
DB01069
Milrinone may decrease the excretion rate of Promethazine which could result in a higher serum level.
DB01093
Milrinone may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.
DB01099
Milrinone may decrease the excretion rate of Flucytosine which could result in a higher serum level.
DB01101
Milrinone may decrease the excretion rate of Capecitabine which could result in a higher serum level.
DB01105
Milrinone may decrease the excretion rate of Sibutramine which could result in a higher serum level.
DB01124
Milrinone may decrease the excretion rate of Tolbutamide which could result in a higher serum level.
DB01129
Milrinone may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
DB01133
Milrinone may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.
DB01135
Milrinone may decrease the excretion rate of Doxacurium which could result in a higher serum level.
DB01137
Milrinone may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
DB01148
Milrinone may decrease the excretion rate of Flavoxate which could result in a higher serum level.
DB01156
Milrinone may decrease the excretion rate of Bupropion which could result in a higher serum level.
DB01157
Milrinone may decrease the excretion rate of Trimetrexate which could result in a higher serum level.
DB01169
Milrinone may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
DB01181
Milrinone may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
DB01183
Milrinone may decrease the excretion rate of Naloxone which could result in a higher serum level.
DB01205
Milrinone may decrease the excretion rate of Flumazenil which could result in a higher serum level.
DB01213
Milrinone may decrease the excretion rate of Fomepizole which could result in a higher serum level.
DB01215
Milrinone may decrease the excretion rate of Estazolam which could result in a higher serum level.
DB01221
Milrinone may decrease the excretion rate of Ketamine which could result in a higher serum level.
DB01222
Milrinone may decrease the excretion rate of Budesonide which could result in a higher serum level.
DB01233
Milrinone may decrease the excretion rate of Metoclopramide which could result in a higher serum level.
DB01241
Milrinone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
DB01249
Milrinone may decrease the excretion rate of Iodixanol which could result in a higher serum level.
DB01261
Milrinone may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
DB01273
Milrinone may decrease the excretion rate of Varenicline which could result in a higher serum level.
DB01274
Milrinone may decrease the excretion rate of Arformoterol which could result in a higher serum level.
DB01367
Milrinone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
DB01394
Milrinone may decrease the excretion rate of Colchicine which could result in a higher serum level.
DB01409
Milrinone may decrease the excretion rate of Tiotropium which could result in a higher serum level.
DB01420
Milrinone may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.
DB01428
Milrinone may decrease the excretion rate of Oxybenzone which could result in a higher serum level.
DB01431
Milrinone may decrease the excretion rate of Allylestrenol which could result in a higher serum level.
DB01550
Milrinone may decrease the excretion rate of Fenproporex which could result in a higher serum level.
DB01558
Milrinone may decrease the excretion rate of Bromazepam which could result in a higher serum level.
DB01563
Milrinone may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.
DB01577
Milrinone may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
DB01587
Milrinone may decrease the excretion rate of Ketazolam which could result in a higher serum level.
DB01610
Milrinone may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
DB01638
Milrinone may decrease the excretion rate of Sorbitol which could result in a higher serum level.
DB01656
Milrinone may decrease the excretion rate of Roflumilast which could result in a higher serum level.
DB01685
Milrinone may decrease the excretion rate of Topiroxostat which could result in a higher serum level.
DB04574
Milrinone may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.
DB04871
Milrinone may decrease the excretion rate of Lorcaserin which could result in a higher serum level.
DB04895
Milrinone may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
DB04896
Milrinone may decrease the excretion rate of Milnacipran which could result in a higher serum level.
DB04920
Milrinone may decrease the excretion rate of Clevidipine which could result in a higher serum level.
DB04953
Milrinone may decrease the excretion rate of Ezogabine which could result in a higher serum level.
DB05018
Milrinone may decrease the excretion rate of Migalastat which could result in a higher serum level.
DB05541
Milrinone may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
DB05676
Milrinone may decrease the excretion rate of Apremilast which could result in a higher serum level.
DB06186
Milrinone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
DB06196
Milrinone may decrease the excretion rate of Icatibant which could result in a higher serum level.
DB06203
Milrinone may decrease the excretion rate of Alogliptin which could result in a higher serum level.
DB06209
Milrinone may decrease the excretion rate of Prasugrel which could result in a higher serum level.
DB06211
Milrinone may decrease the excretion rate of Doripenem which could result in a higher serum level.
DB06228
Milrinone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
DB06230
Milrinone may decrease the excretion rate of Nalmefene which could result in a higher serum level.
DB06262
Milrinone may decrease the excretion rate of Droxidopa which could result in a higher serum level.
DB06282
Milrinone may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
DB06335
Milrinone may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
DB06402
Milrinone may decrease the excretion rate of Telavancin which could result in a higher serum level.
DB06480
Milrinone may decrease the excretion rate of Prucalopride which could result in a higher serum level.
DB06623
Milrinone may decrease the excretion rate of Flupirtine which could result in a higher serum level.
DB06637
Milrinone may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
DB06695
Milrinone may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.
DB06700
Milrinone may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.
DB06702
Milrinone may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
DB06705
Milrinone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.
DB06710
Milrinone may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.
DB06767
Milrinone may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.
DB06782
Milrinone may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
DB06796
Milrinone may decrease the excretion rate of Mangafodipir which could result in a higher serum level.
DB06800
Milrinone may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
DB06809
Milrinone may decrease the excretion rate of Plerixafor which could result in a higher serum level.
DB06813
Milrinone may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
DB06823
Milrinone may decrease the excretion rate of Tiopronin which could result in a higher serum level.
DB06824
Milrinone may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.
DB08824
Milrinone may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.
DB08826
Milrinone may decrease the excretion rate of Deferiprone which could result in a higher serum level.
DB08840
Milrinone may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.
DB08872
Milrinone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.
DB08877
Milrinone may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
DB08893
Milrinone may decrease the excretion rate of Mirabegron which could result in a higher serum level.
DB08894
Milrinone may decrease the excretion rate of Peginesatide which could result in a higher serum level.
DB08897
Milrinone may decrease the excretion rate of Aclidinium which could result in a higher serum level.
DB08899
Milrinone may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
DB08900
Milrinone may decrease the excretion rate of Teduglutide which could result in a higher serum level.
DB08904
Milrinone may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.
DB08905
Milrinone may decrease the excretion rate of Formestane which could result in a higher serum level.
DB08909
Milrinone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.
DB08910
Milrinone may decrease the excretion rate of Pomalidomide which could result in a higher serum level.
DB08911
Milrinone may decrease the excretion rate of Trametinib which could result in a higher serum level.
DB08918
Milrinone may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
DB08934
Milrinone may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
DB09027
Milrinone may decrease the excretion rate of Ledipasvir which could result in a higher serum level.
DB09050
Milrinone may decrease the excretion rate of Ceftolozane which could result in a higher serum level.
DB09066
Milrinone may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.
DB09068
Milrinone may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
DB09071
Milrinone may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
DB09075
Milrinone may decrease the excretion rate of Edoxaban which could result in a higher serum level.
DB09081
Milrinone may decrease the excretion rate of Idebenone which could result in a higher serum level.
DB09082
Milrinone may decrease the excretion rate of Vilanterol which could result in a higher serum level.
DB09089
Milrinone may decrease the excretion rate of Trimebutine which could result in a higher serum level.
DB09091
Milrinone may decrease the excretion rate of Tixocortol which could result in a higher serum level.
DB09103
Milrinone may decrease the excretion rate of Ancestim which could result in a higher serum level.
DB09104
Milrinone may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
DB09106
Milrinone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.
DB09111
Milrinone may decrease the excretion rate of Pentastarch which could result in a higher serum level.
DB09118
Milrinone may decrease the excretion rate of Stiripentol which could result in a higher serum level.
DB09121
Milrinone may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.
DB09123
Milrinone may decrease the excretion rate of Dienogest which could result in a higher serum level.
DB09129
Milrinone may decrease the excretion rate of Chromic chloride which could result in a higher serum level.
DB09132
Milrinone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.
DB09133
Milrinone may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
DB09134
Milrinone may decrease the excretion rate of Ioversol which could result in a higher serum level.
DB09135
Milrinone may decrease the excretion rate of Ioxilan which could result in a higher serum level.
DB09136
Milrinone may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.
DB09137
Milrinone may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.
DB09139
Milrinone may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.
DB09148
Milrinone may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.
DB09149
Milrinone may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.
DB09156
Milrinone may decrease the excretion rate of Iopromide which could result in a higher serum level.
DB09163
Milrinone may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.
DB09165
Milrinone may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.
DB09185
Milrinone may decrease the excretion rate of Viloxazine which could result in a higher serum level.
DB09194
Milrinone may decrease the excretion rate of Etoperidone which could result in a higher serum level.
DB09195
Milrinone may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.
DB09204
Milrinone may decrease the excretion rate of Arotinolol which could result in a higher serum level.
DB09205
Milrinone may decrease the excretion rate of Moxisylyte which could result in a higher serum level.
DB09209
Milrinone may decrease the excretion rate of Pholcodine which could result in a higher serum level.
DB09210
Milrinone may decrease the excretion rate of Piracetam which could result in a higher serum level.
DB09219
Milrinone may decrease the excretion rate of Bisoxatin which could result in a higher serum level.
DB09223
Milrinone may decrease the excretion rate of Blonanserin which could result in a higher serum level.
DB09224
Milrinone may decrease the excretion rate of Melperone which could result in a higher serum level.
DB09241
Milrinone may decrease the excretion rate of Methylene blue which could result in a higher serum level.
DB09244
Milrinone may decrease the excretion rate of Pirlindole which could result in a higher serum level.
DB09245
Milrinone may decrease the excretion rate of Toloxatone which could result in a higher serum level.
DB09255
Milrinone may decrease the excretion rate of Dextran which could result in a higher serum level.
DB09256
Milrinone may decrease the excretion rate of Tegafur which could result in a higher serum level.
DB09257
Milrinone may decrease the excretion rate of Gimeracil which could result in a higher serum level.
DB09262
Milrinone may decrease the excretion rate of Imidafenacin which could result in a higher serum level.
DB09264
Milrinone may decrease the excretion rate of Idarucizumab which could result in a higher serum level.
DB09265
Milrinone may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
DB09268
Milrinone may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.
DB09276
Milrinone may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.
DB09277
Milrinone may decrease the excretion rate of Choline C 11 which could result in a higher serum level.
DB09281
Milrinone may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.
DB09292
Milrinone may decrease the excretion rate of Sacubitril which could result in a higher serum level.
DB09301
Milrinone may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.
DB09317
Milrinone may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.
DB09318
Milrinone may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.
DB09320
Milrinone may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
DB09324
Milrinone may decrease the excretion rate of Sulbactam which could result in a higher serum level.
DB09325
Milrinone may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.
DB09329
Milrinone may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.
DB09344
Milrinone may decrease the excretion rate of Invert sugar which could result in a higher serum level.
DB09357
Milrinone may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
DB09394
Milrinone may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.
DB09395
Milrinone may decrease the excretion rate of Sodium acetate which could result in a higher serum level.
DB09407
Milrinone may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.
DB09418
Milrinone may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.
DB09472
Milrinone may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.
DB09481
Milrinone may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.
DB09488
Milrinone may decrease the excretion rate of Acrivastine which could result in a higher serum level.
DB09496
Milrinone may decrease the excretion rate of Octinoxate which could result in a higher serum level.
DB09502
Milrinone may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.
DB09546
Milrinone may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.
DB09570
Milrinone may decrease the excretion rate of Ixazomib which could result in a higher serum level.
DB11077
Milrinone may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.
DB11090
Milrinone may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.
DB11098
Milrinone may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.
DB11102
Milrinone may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.
DB11114
Milrinone may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.
DB11127
Milrinone may decrease the excretion rate of Selenious acid which could result in a higher serum level.
DB11130
Milrinone may decrease the excretion rate of Opium which could result in a higher serum level.
DB11135
Milrinone may decrease the excretion rate of Selenium which could result in a higher serum level.
DB11136
Milrinone may decrease the excretion rate of Chromium which could result in a higher serum level.
DB11145
Milrinone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.
DB11156
Milrinone may decrease the excretion rate of Pyrantel which could result in a higher serum level.
DB11164
Milrinone may decrease the excretion rate of Bicisate which could result in a higher serum level.
DB11251
Milrinone may decrease the excretion rate of Tocopherol which could result in a higher serum level.
DB11278
Milrinone may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.
DB11328
Milrinone may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.
DB11338
Milrinone may decrease the excretion rate of Clove oil which could result in a higher serum level.
DB11358
Milrinone may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.
DB11364
Milrinone may decrease the excretion rate of Pidotimod which could result in a higher serum level.
DB11560
Milrinone may decrease the excretion rate of Lesinurad which could result in a higher serum level.
DB11577
Milrinone may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.
DB11587
Milrinone may decrease the excretion rate of Etafedrine which could result in a higher serum level.
DB11598
Milrinone may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.
DB11642
Milrinone may decrease the excretion rate of Pitolisant which could result in a higher serum level.
DB11691
Milrinone may decrease the excretion rate of Naldemedine which could result in a higher serum level.
DB11699
Milrinone may decrease the excretion rate of Tropisetron which could result in a higher serum level.
DB11817
Milrinone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
DB11901
Milrinone may decrease the excretion rate of Apalutamide which could result in a higher serum level.
DB11915
Milrinone may decrease the excretion rate of Valbenazine which could result in a higher serum level.
DB11943
Milrinone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
DB11989
Milrinone may decrease the excretion rate of Benznidazole which could result in a higher serum level.
DB12007
Milrinone may decrease the excretion rate of Isoflavone which could result in a higher serum level.
DB12107
Milrinone may decrease the excretion rate of Vaborbactam which could result in a higher serum level.
DB12161
Milrinone may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
DB12783
Milrinone may decrease the excretion rate of Benserazide which could result in a higher serum level.
DB13025
Milrinone may decrease the excretion rate of Tiapride which could result in a higher serum level.
DB13139
Milrinone may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.
DB13156
Milrinone may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.
DB13178
Milrinone may decrease the excretion rate of Inositol which could result in a higher serum level.
DB13185
Milrinone may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.
DB13191
Milrinone may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.
DB13269
Milrinone may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.
DB13293
Milrinone may decrease the excretion rate of Ipecac which could result in a higher serum level.
DB13595
Milrinone may decrease the excretion rate of Almasilate which could result in a higher serum level.
DB13873
Milrinone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.
DB13884
Milrinone may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.
DB13909
Milrinone may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.
DB13943
Milrinone may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.
DB13944
Milrinone may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.
DB13946
Milrinone may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.
DB13952
Milrinone may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.
DB13954
Milrinone may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.
DB13955
Milrinone may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.
DB13956
Milrinone may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.
DB14006
Milrinone may decrease the excretion rate of Choline salicylate which could result in a higher serum level.
DB14007
Milrinone may decrease the excretion rate of Pentetic acid which could result in a higher serum level.
DB14498
Milrinone may decrease the excretion rate of Potassium acetate which could result in a higher serum level.
DB14499
Milrinone may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.
DB14526
Milrinone may decrease the excretion rate of Chromic citrate which could result in a higher serum level.
DB14527
Milrinone may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.
DB14528
Milrinone may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.
DB14529
Milrinone may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.
DB14530
Milrinone may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.
DB14754
Milrinone may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
DB06815
Milrinone may decrease the excretion rate of Pyrithione which could result in a higher serum level.
DB11121
Milrinone may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.
DB11085
Milrinone may decrease the excretion rate of Resorcinol which could result in a higher serum level.
DB15593
Milrinone may decrease the excretion rate of Golodirsen which could result in a higher serum level.
DB00318
Milrinone may decrease the excretion rate of Codeine which could result in a higher serum level.
DB00454
Milrinone may decrease the excretion rate of Meperidine which could result in a higher serum level.
DB00813
Milrinone may decrease the excretion rate of Fentanyl which could result in a higher serum level.
DB00879
Milrinone may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
DB01151
Milrinone may decrease the excretion rate of Desipramine which could result in a higher serum level.
DB01242
Milrinone may decrease the excretion rate of Clomipramine which could result in a higher serum level.
DB08996
Milrinone may decrease the excretion rate of Dimetacrine which could result in a higher serum level.
DB14506
Milrinone may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
DB13987
Milrinone may decrease the excretion rate of Strontium chloride which could result in a higher serum level.
DB04890
Milrinone may decrease the excretion rate of Bepotastine which could result in a higher serum level.
DB00982
Milrinone may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
DB04930
Milrinone may decrease the excretion rate of Permethrin which could result in a higher serum level.
DB09095
Milrinone may decrease the excretion rate of Difluocortolone which could result in a higher serum level.
DB00479
Amikacin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00684
Tobramycin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00798
Gentamicin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00955
Netilmicin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00994
Neomycin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01082
Streptomycin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB01172
Kanamycin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB03615
Ribostamycin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB04729
Gentamicin C1a may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB06696
Arbekacin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB12604
Sisomicin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB13540
Isepamicin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00552
Milrinone may decrease the excretion rate of Pentostatin which could result in a higher serum level.
DB13145
Milrinone may decrease the excretion rate of Nedaplatin which could result in a higher serum level.
DB00314
Milrinone may decrease the excretion rate of Capreomycin which could result in a higher serum level.
DB00390
Milrinone may decrease the excretion rate of Digoxin which could result in a higher serum level.
DB00512
Milrinone may decrease the excretion rate of Vancomycin which could result in a higher serum level.
DB00515
Milrinone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
DB00564
Milrinone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
DB00642
Milrinone may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
DB00682
Milrinone may decrease the excretion rate of Warfarin which could result in a higher serum level.
DB00908
Milrinone may decrease the excretion rate of Quinidine which could result in a higher serum level.
DB01035
Milrinone may decrease the excretion rate of Procainamide which could result in a higher serum level.
DB12615
Milrinone may decrease the excretion rate of Plazomicin which could result in a higher serum level.
DB14509
Milrinone may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.
DB00803
Colistin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB09220
Milrinone may increase the hypotensive activities of Nicorandil.
DB00214
Milrinone may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
DB00310
Milrinone may increase the excretion rate of Chlorthalidone which could result in a lower serum level and potentially a reduction in efficacy.
DB00436
Milrinone may increase the excretion rate of Bendroflumethiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB00524
Milrinone may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.
DB00606
Milrinone may increase the excretion rate of Cyclothiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB00700
Milrinone may increase the excretion rate of Eplerenone which could result in a lower serum level and potentially a reduction in efficacy.
DB00774
Milrinone may increase the excretion rate of Hydroflumethiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB00808
Milrinone may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.
DB00880
Milrinone may increase the excretion rate of Chlorothiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB01021
Milrinone may increase the excretion rate of Trichlormethiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB01119
Milrinone may increase the excretion rate of Diazoxide which could result in a lower serum level and potentially a reduction in efficacy.
DB01324
Milrinone may increase the excretion rate of Polythiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB04831
Milrinone may increase the excretion rate of Tienilic acid which could result in a lower serum level and potentially a reduction in efficacy.
DB09235
Milrinone may increase the excretion rate of Efonidipine which could result in a lower serum level and potentially a reduction in efficacy.
DB12766
Milrinone may increase the excretion rate of Cicletanine which could result in a lower serum level and potentially a reduction in efficacy.
DB13532
Milrinone may increase the excretion rate of Cyclopenthiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB13801
Milrinone may increase the excretion rate of Muzolimine which could result in a lower serum level and potentially a reduction in efficacy.
DB13803
Milrinone may increase the excretion rate of Xipamide which could result in a lower serum level and potentially a reduction in efficacy.
DB00695
Milrinone may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
DB00887
Milrinone may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
DB00909
Milrinone may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.
DB08907
Milrinone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
DB09338
Milrinone may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.
DB00232
Methyclothiazide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB00311
Ethoxzolamide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB00421
Spironolactone may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB00562
Benzthiazide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB00594
Amiloride may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB00703
Methazolamide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB00819
Acetazolamide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB00872
Conivaptan may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB01144
Diclofenamide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB01325
Quinethazone may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB01395
Drospirenone may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB01412
Theobromine may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB02925
Piretanide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB05034
Ularitide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB06212
Tolvaptan may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB06292
Dapagliflozin may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB06370
Indisulam may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB08961
Azosemide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB09015
Canrenoic acid may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB09125
Potassium citrate may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB11827
Ertugliflozin may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB12221
Canrenone may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB12670
Rolofylline may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB12704
Spiradoline may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB13284
Meticrane may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB13405
Mefruside may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB13430
Mebutizide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB13617
Clorexolone may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB13663
Clofenamide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB13708
Fenquizone may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB13792
Clopamide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB13989
Epitizide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB14018
Bromotheophylline may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB14500
Potassium may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.
DB01345
Milrinone may increase the excretion rate of Potassium cation which could result in a lower serum level and potentially a reduction in efficacy.
DB00590
The risk or severity of hypotension can be increased when Milrinone is combined with Doxazosin.
DB00388
The risk or severity of hypertension can be decreased when Milrinone is combined with Phenylephrine.
DB01115
The risk or severity of hypotension can be increased when Milrinone is combined with Nifedipine.
DB01020
Milrinone may increase the vasodilatory activities of Isosorbide mononitrate.
DB01601
The serum concentration of Milrinone can be increased when it is combined with Lopinavir.
DB00503
The serum concentration of Milrinone can be increased when it is combined with Ritonavir.
DB00086
The risk or severity of hypotension can be increased when Milrinone is combined with Streptokinase.
DB00268
The risk or severity of hypotension can be increased when Milrinone is combined with Ropinirole.
DB00295
The risk or severity of hypotension can be increased when Milrinone is combined with Morphine.
DB00297
The risk or severity of hypotension can be increased when Milrinone is combined with Bupivacaine.
DB00484
The risk or severity of hypotension can be increased when Milrinone is combined with Brimonidine.
DB00486
The risk or severity of hypotension can be increased when Milrinone is combined with Nabilone.
DB00489
The risk or severity of hypotension can be increased when Milrinone is combined with Sotalol.
DB00521
The risk or severity of hypotension can be increased when Milrinone is combined with Carteolol.
DB00599
The risk or severity of hypotension can be increased when Milrinone is combined with Thiopental.
DB00697
The risk or severity of hypotension can be increased when Milrinone is combined with Tizanidine.
DB00708
The risk or severity of hypotension can be increased when Milrinone is combined with Sufentanil.
DB00714
The risk or severity of hypotension can be increased when Milrinone is combined with Apomorphine.
DB00752
The risk or severity of hypotension can be increased when Milrinone is combined with Tranylcypromine.
DB00753
The risk or severity of hypotension can be increased when Milrinone is combined with Isoflurane.
DB00755
The risk or severity of hypotension can be increased when Milrinone is combined with Tretinoin.
DB00818
The risk or severity of hypotension can be increased when Milrinone is combined with Propofol.
DB00899
The risk or severity of hypotension can be increased when Milrinone is combined with Remifentanil.
DB00922
The risk or severity of hypotension can be increased when Milrinone is combined with Levosimendan.
DB00964
The risk or severity of hypotension can be increased when Milrinone is combined with Apraclonidine.
DB01037
The risk or severity of hypotension can be increased when Milrinone is combined with Selegiline.
DB01041
The risk or severity of hypotension can be increased when Milrinone is combined with Thalidomide.
DB01088
The risk or severity of hypotension can be increased when Milrinone is combined with Iloprost.
DB01113
The risk or severity of hypotension can be increased when Milrinone is combined with Papaverine.
DB01118
The risk or severity of hypotension can be increased when Milrinone is combined with Amiodarone.
DB01143
The risk or severity of hypotension can be increased when Milrinone is combined with Amifostine.
DB01159
The risk or severity of hypotension can be increased when Milrinone is combined with Halothane.
DB01189
The risk or severity of hypotension can be increased when Milrinone is combined with Desflurane.
DB01210
The risk or severity of hypotension can be increased when Milrinone is combined with Levobunolol.
DB01214
The risk or severity of hypotension can be increased when Milrinone is combined with Metipranolol.
DB01229
The risk or severity of hypotension can be increased when Milrinone is combined with Paclitaxel.
DB01235
The risk or severity of hypotension can be increased when Milrinone is combined with Levodopa.
DB01236
The risk or severity of hypotension can be increased when Milrinone is combined with Sevoflurane.
DB01247
The risk or severity of hypotension can be increased when Milrinone is combined with Isocarboxazid.
DB01282
The risk or severity of hypotension can be increased when Milrinone is combined with Carbetocin.
DB04899
The risk or severity of hypotension can be increased when Milrinone is combined with Nesiritide.
DB05271
The risk or severity of hypotension can be increased when Milrinone is combined with Rotigotine.
DB08822
The risk or severity of hypotension can be increased when Milrinone is combined with Azilsartan medoxomil.
DB08935
The risk or severity of hypotension can be increased when Milrinone is combined with Obinutuzumab.
DB08941
The risk or severity of hypotension can be increased when Milrinone is combined with Isoxsuprine.
DB09038
The risk or severity of hypotension can be increased when Milrinone is combined with Empagliflozin.
DB09077
The risk or severity of hypotension can be increased when Milrinone is combined with Dinutuximab.
DB09112
The risk or severity of hypotension can be increased when Milrinone is combined with Nitrous acid.
DB09227
The risk or severity of hypotension can be increased when Milrinone is combined with Barnidipine.
DB09232
The risk or severity of hypotension can be increased when Milrinone is combined with Cilnidipine.
DB09279
The risk or severity of hypotension can be increased when Milrinone is combined with Fimasartan.
DB09286
The risk or severity of hypotension can be increased when Milrinone is combined with Pipamperone.

序列

实验性质

Water Solubility
Slightly soluble

Melting Point
>300 °C
PhysProp
logP
0.4

外部标识符

resource：Drugs Product Database (DPD)
identifier：1216
resource：ChEBI
identifier：50693
resource：PubChem Compound
identifier：4197
resource：PubChem Substance
identifier：46507838
resource：KEGG Compound
identifier：C07224
resource：KEGG Drug
identifier：D00417
resource：ChemSpider
identifier：4052
resource：BindingDB
identifier：15296
resource：PharmGKB
identifier：PA164749171
resource：PDB
identifier：MIL
resource：Therapeutic Targets Database
identifier：DAP000150
resource：Wikipedia
identifier：Milrinone
resource：ChEMBL
identifier：CHEMBL189
resource：ZINC
identifier：ZINC000009224016
resource：RxCUI
identifier：52769

外部链接

RxList
http://www.rxlist.com/cgi/generic3/milrin.htm
Drugs.com
http://www.drugs.com/cdi/milrinone.html

路径

目标

id:BE0000436
name:cGMP-inhibited 3',5'-cyclic phosphodiesterase A
organism:Humans
action:inhibitor
Cone J, Wang S, Tandon N, Fong M, Sun B, Sakurai K, Yoshitake M, Kambayashi J, Liu Y: Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells. J Cardiovasc Pharmacol. 1999 Oct;34(4):497-504.
Kuthe A, Magert H, Uckert S, Forssmann WG, Stief CG, Jonas U: Gene expression of the phosphodiesterases 3A and 5A in human corpus cavernosum penis. Eur Urol. 2000 Jul;38(1):108-14.
Lefievre L, de Lamirande E, Gagnon C: Presence of cyclic nucleotide phosphodiesterases PDE1A, existing as a stable complex with calmodulin, and PDE3A in human spermatozoa. Biol Reprod. 2002 Aug;67(2):423-30.
Zhang W, Ke H, Colman RW: Identification of interaction sites of cyclic nucleotide phosphodiesterase type 3A with milrinone and cilostazol using molecular modeling and site-directed mutagenesis. Mol Pharmacol. 2002 Sep;62(3):514-20.
Shakur Y, Fong M, Hensley J, Cone J, Movsesian MA, Kambayashi J, Yoshitake M, Liu Y: Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart. Cardiovasc Drugs Ther. 2002 Sep;16(5):417-27.
Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
known-action:yes
name:cGMP-inhibited 3',5'-cyclic phosphodiesterase A
general-function:Metal ion binding
specific-function:Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes.
gene-name:PDE3A
locus:12p12
cellular-location:Membrane
transmembrane-regions:61-81 130-150 160-180 185-205 210-230 232-252
signal-regions:
theoretical-pi:5.87
molecular-weight:124978.06
chromosome-location:12
organism:Humans
external-identifiers:HUGO Gene Nomenclature Committee (HGNC)HGNC:8778GenAtlasPDE3AGenBank Gene DatabaseM91667GenBank Protein Database38201493Guide to Pharmacology1298UniProtKBQ14432UniProt AccessionPDE3A_HUMAN
synonyms:3.1.4.17CGI-PDE ACyclic GMP-inhibited phosphodiesterase A
amino-acid-sequence:>lcl|BSEQ0021260|cGMP-inhibited 3',5'-cyclic phosphodiesterase A MAVPGDAARVRDKPVHSGVSQAPTAGRDCHHRADPASPRDSGCRGCWGDLVLQPLRSSRK LSSALCAGSLSFLLALLVRLVRGEVGCDLEQCKEAAAAEEEEAAPGAEGGVFPGPRGGAP GGGARLSPWLQPSALLFSLLCAFFWMGLYLLRAGVRLPLAVALLAACCGGEALVQIGLGV GEDHLLSLPAAGVVLSCLAAATWLVLRLRLGVLMIALTSAVRTVSLISLERFKVAWRPYL AYLAGVLGILLARYVEQILPQSAEAAPREHLGSQLIAGTKEDIPVFKRRRRSSSVVSAEM SGCSSKSHRRTSLPCIPREQLMGHSEWDHKRGPRGSQSSGTSITVDIAVMGEAHGLITDL LADPSLPPNVCTSLRAVSNLLSTQLTFQAIHKPRVNPVTSLSENYTCSDSEESSEKDKLA IPKRLRRSLPPGLLRRVSSTWTTTTSATGLPTLEPAPVRRDRSTSIKLQEAPSSSPDSWN NPVMMTLTKSRSFTSSYAISAANHVKAKKQSRPGALAKISPLSSPCSSPLQGTPASSLVS KISAVQFPESADTTAKQSLGSHRALTYTQSAPDLSPQILTPPVICSSCGRPYSQGNPADE PLERSGVATRTPSRTDDTAQVTSDYETNNNSDSSDIVQNEDETECLREPLRKASACSTYA PETMMFLDKPILAPEPLVMDNLDSIMEQLNTWNFPIFDLVENIGRKCGRILSQVSYRLFE DMGLFEAFKIPIREFMNYFHALEIGYRDIPYHNRIHATDVLHAVWYLTTQPIPGLSTVIN DHGSTSDSDSDSGFTHGHMGYVFSKTYNVTDDKYGCLSGNIPALELMALYVAAAMHDYDH PGRTNAFLVATSAPQAVLYNDRSVLENHHAAAAWNLFMSRPEYNFLINLDHVEFKHFRFL VIEAILATDLKKHFDFVAKFNGKVNDDVGIDWTNENDRLLVCQMCIKLADINGPAKCKEL HLQWTDGIVNEFYEQGDEEASLGLPISPFMDRSAPQLANLQESFISHIVGPLCNSYDSAG LMPGKWVEDSDESGDTDDPEEEEEEAPAPNEEETCENNESPKKKTFKRRKIYCQITQHLL QNHKMWKKVIEEEQRLAGIENQSLDQTPQSHSSEQIQAIKEEEEEKGKPRGEEIPTQKPD Q
gene-sequence:>lcl|BSEQ0021261|cGMP-inhibited 3',5'-cyclic phosphodiesterase A (PDE3A) ATGGCAGTGCCCGGCGACGCTGCACGAGTCAGGGACAAGCCCGTCCACAGTGGGGTGAGT CAAGCCCCCACGGCGGGCCGGGACTGCCACCATCGTGCGGACCCCGCATCGCCGCGGGAC TCGGGCTGCCGTGGCTGCTGGGGAGACCTGGTGCTGCAGCCGCTCCGGAGCTCTCGGAAA CTTTCCTCCGCGCTGTGCGCGGGCTCCCTGTCCTTTCTGCTGGCGCTGCTGGTGAGGCTG GTCCGCGGGGAGGTCGGCTGTGACCTGGAGCAGTGTAAGGAGGCGGCGGCGGCGGAGGAG GAGGAAGCAGCCCCGGGAGCAGAAGGGGGCGTCTTCCCGGGGCCTCGGGGAGGTGCTCCC GGGGGCGGTGCGCGGCTCAGCCCCTGGCTGCAGCCCTCGGCGCTGCTCTTCAGTCTCCTG TGTGCCTTCTTCTGGATGGGCTTGTACCTCCTGCGCGCCGGGGTGCGCCTGCCTCTGGCT GTCGCGCTGCTGGCCGCCTGCTGCGGGGGGGAAGCGCTCGTCCAGATTGGGCTGGGCGTC GGGGAGGATCACTTACTCTCACTCCCCGCCGCGGGGGTGGTGCTCAGCTGCTTGGCCGCC GCGACATGGCTGGTGCTGAGGCTGAGGCTGGGCGTCCTCATGATCGCCTTGACTAGCGCG GTCAGGACCGTGTCCCTCATTTCCTTAGAGAGGTTCAAGGTCGCCTGGAGACCTTACCTG GCGTACCTGGCCGGCGTGCTGGGGATCCTCTTGGCCAGGTACGTGGAACAAATCTTGCCG CAGTCCGCGGAGGCGGCTCCAAGGGAGCATTTGGGGTCCCAGCTGATTGCTGGGACCAAG GAAGATATCCCGGTGTTTAAGAGGAGGAGGCGGTCCAGCTCCGTCGTGTCCGCCGAGATG TCCGGCTGCAGCAGCAAGTCCCATCGGAGGACCTCCCTGCCCTGTATACCGAGGGAACAG CTCATGGGGCATTCAGAATGGGACCACAAACGAGGGCCAAGAGGATCACAGTCTTCAGGA ACCAGTATTACTGTGGACATCGCCGTCATGGGCGAGGCCCACGGCCTCATTACCGACCTC CTGGCAGACCCTTCTCTTCCACCAAACGTGTGCACATCCTTGAGAGCCGTGAGCAACTTG CTCAGCACACAGCTCACCTTCCAGGCCATTCACAAGCCCAGAGTGAATCCCGTCACTTCG CTCAGTGAAAACTATACCTGTTCTGACTCTGAAGAGAGCTCTGAAAAAGACAAGCTTGCT ATTCCAAAGCGCCTGAGAAGGAGTTTGCCTCCTGGCTTGTTGAGACGAGTTTCTTCCACT TGGACCACCACCACCTCGGCCACAGGTCTACCCACCTTGGAGCCTGCACCAGTACGGAGA GACCGCAGCACCAGCATCAAACTGCAGGAAGCACCTTCATCCAGTCCTGATTCTTGGAAT AATCCAGTGATGATGACCCTCACCAAAAGCAGATCCTTTACTTCATCCTATGCTATTTCT GCAGCTAACCATGTAAAGGCTAAAAAGCAAAGTCGACCAGGTGCCCTCGCTAAAATTTCA CCTCTTTCATCGCCCTGCTCCTCACCTCTCCAAGGGACTCCTGCCAGCAGCCTGGTCAGC AAAATTTCTGCAGTGCAGTTTCCAGAATCTGCTGACACAACTGCCAAACAAAGCCTAGGT TCTCACAGGGCCTTAACTTACACTCAGAGTGCCCCAGACCTATCCCCTCAAATCCTGACT CCACCTGTTATATGTAGCAGCTGTGGCAGACCATATTCCCAAGGGAATCCTGCTGATGAG CCCCTGGAGAGAAGTGGGGTAGCCACTCGGACACCAAGTAGAACAGATGACACTGCTCAA GTTACCTCTGATTATGAAACCAATAACAACAGTGACAGCAGTGACATTGTACAGAATGAA GATGAAACAGAGTGCCTGAGAGAGCCTCTGAGGAAAGCATCGGCTTGCAGCACCTATGCT CCTGAGACCATGATGTTTCTGGACAAACCAATTCTTGCTCCCGAACCTCTTGTCATGGAT AACCTGGACTCAATTATGGAGCAGCTAAATACTTGGAATTTTCCAATTTTTGATTTAGTG GAAAATATAGGAAGAAAATGTGGCCGTATTCTTAGTCAGGTATCTTACAGACTTTTTGAA GACATGGGCCTCTTTGAAGCTTTTAAAATTCCAATTAGGGAATTTATGAATTATTTTCAT GCTTTGGAGATTGGATATAGGGATATTCCTTATCATAACAGAATCCATGCCACTGATGTT TTACATGCTGTTTGGTATCTTACTACACAGCCTATTCCAGGCCTCTCAACTGTGATTAAT GATCATGGTTCAACCAGTGATTCAGATTCTGACAGTGGATTTACACATGGACATATGGGA TATGTATTCTCAAAAACGTATAATGTGACAGATGATAAATACGGATGTCTGTCTGGGAAT ATCCCTGCCTTGGAGTTGATGGCGCTGTATGTGGCTGCAGCCATGCACGATTATGATCAT CCAGGAAGGACTAATGCTTTCCTGGTTGCAACTAGTGCTCCTCAGGCGGTGCTATATAAC GATCGTTCAGTTTTGGAGAATCATCACGCAGCTGCTGCATGGAATCTTTTCATGTCCCGG CCAGAGTATAACTTCTTAATTAACCTTGACCATGTGGAATTTAAGCATTTCCGTTTCCTT GTCATTGAAGCAATTTTGGCCACTGACCTGAAGAAACACTTTGACTTCGTAGCCAAATTT AATGGCAAGGTAAATGATGATGTTGGAATAGATTGGACCAATGAAAATGATCGTCTACTG GTTTGTCAAATGTGTATAAAGTTGGCTGATATCAATGGTCCAGCTAAATGTAAAGAACTC CATCTTCAGTGGACAGATGGTATTGTCAATGAATTTTATGAACAGGGTGATGAAGAGGCC AGCCTTGGATTACCCATAAGCCCCTTCATGGATCGTTCTGCTCCTCAGCTGGCCAACCTT CAGGAATCCTTCATCTCTCACATTGTGGGGCCTCTGTGCAACTCCTATGATTCAGCAGGA CTAATGCCTGGAAAATGGGTGGAAGACAGCGATGAGTCAGGAGATACTGATGACCCAGAA GAAGAGGAGGAAGAAGCACCAGCACCAAATGAAGAGGAAACCTGTGAAAATAATGAATCT CCAAAAAAGAAGACTTTCAAAAGGAGAAAAATCTACTGCCAAATAACTCAGCACCTCTTA CAGAACCACAAGATGTGGAAGAAAGTCATTGAAGAGGAGCAACGGTTGGCAGGCATAGAA AATCAATCCCTGGACCAGACCCCTCAGTCGCACTCTTCAGAACAGATCCAGGCTATCAAG GAAGAAGAAGAAGAGAAAGGGAAACCAAGAGGCGAGGAGATACCAACCCAAAAGCCAGAC CAGTGA
pfams:PF00233PDEase_I
go-classifiers:componentcytosolcomponentintegral component of membranefunction3',5'-cyclic-AMP phosphodiesterase activityfunctioncAMP bindingfunctioncGMP-inhibited cyclic-nucleotide phosphodiesterase activityfunctionmetal ion bindingprocessblood coagulationprocesscAMP catabolic processprocesscAMP-mediated signalingprocesscellular response to cGMPprocesscellular response to transforming growth factor beta stimulusprocesscGMP-mediated signalingprocessditerpenoid metabolic processprocesslipid metabolic processprocessnegative regulation of apoptotic processprocessnegative regulation of vascular permeabilityprocessoocyte maturationprocesspositive regulation of oocyte developmentprocesspositive regulation of vascular permeabilityprocessregulation of meiotic nuclear divisionprocessresponse to cAMPprocessresponse to drug

酶

载体

运输工具

药物反应

效应

不良反应